Synthetic composition for microbiota modulation
US11529365B2 · kind B2 · utility
1Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2020 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Dec 29, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition including an effective amount of one or more synthetic neutral HMOs are disclosed for modulating the microbiota in the gastro-intestinal tracts of non-infant humans who are carriers of the human fucosyltransferase 2 (FUT2) genetic mutation and for improving one or more gastrointestinal conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.